Children's Hospital and Regional Medical Center Pediatric Immunology Attending PhysicianAppointed: 2000 University of Washington School of Medicine Pediatrics Assistant ProfessorAppointed: 2000 University of Washington School of Medicine Department of Immunology Assistant ProfessorAppointed: 2000 |  |
QualificationsM.D., University of North Carolina at Chapel Hill, Pediatrics, 1990. Expertise and Research InterestsMy lab is interested in the molecular analysis of calcium entry mechanisms in the immune system.
Calcium is a critical regulatory second messenger for many types of gene activation events and for events which occur during cell division. The changes in cytosolic calcium which are involved in these types of events are often dependent on the entry of extracellular calcium. Furthermore, other divalent cations also play important roles in the proliferation and survival of non-excitable cells. Therefore, insight into the mechanisms which control the entry of calcium and other divalent cations into non-excitable cells will contribute significantly to our understanding of the mechanisms which regulate cell development and proliferation in both immunologic and non-immunologic contexts. However, to date, little is known about the molecular mechanisms which regulate the entry of calcium or other divalent cations into cells. My laboratory is focused on identifying and characterizing the biochemical mechanisms which regulate the entry of calcium and other divalent cations into immunologic cells and other types of non-excitable cells. I have four major ongoing areas of research:
I) Tec kinase-dependent signaling pathways: A major interest of my laboratory is the characterization of the signaling pathways downstream from Tec kinase activation, one of whose major direct targets is phospholiphase C (an enzyme which causes the production of IP3 and diacylglycerol). In this area, we presently have an ongoing project currently focused on identifying the downstream targets of the DAG-activated kinases PKD and PKCnu. 2) ADP-ribose as a novel calcium entry second messenger My laboratory has recently cloned and demonstrated the existence of an ADP-ribose gated ion channel which is expressed in many types of immune cells and other non-exciteable cells (Nature, 411:590-599). The existence of this channel suggests a novel role for ADPR as a calcium signaling second messenger, and the delineation and characterization of this pathway is presently the focus of a major project in the laboratory. 3) Characterization of a calcium channel required for cell viability My lab also recently cloned the novel LTRPC7 channel and has shown that this channel is an MgATP-regulated ion channel required for cell viability (Nature, 411:590-95). This channel is unique in containing a kinase domain of presently unknown function, and is closely related to the putative melanoma metastasis suppressor gene Melastatin. The analysis of the role of this channel and Melastatin in eukaryotic cellular function is the focus of a major project in my laboratory. 4) Identification of novel regulatory pathways for calcium entry. My lab has cloned and characterized several other putative calcium channels expressed in immune and other non-exciteable cells, and has ongoing projects in several areas. Two of these projects are well along in development, such that I anticipate being able to submit NIH grants on one or more of them sometime in the next year.
Industrial RelevanceI am actively interested in developing therapeutics targeted at ion channels expressed in non-exciteable cells. My laboratory and myself now have extensive experience in the expression and characterization of non-voltage activated ion channels, includinga library of cell lines either expressing various types of ion channels or lacking their expression. We have also developed or are developing assays suiteable for high throughput drug screening for each channel of interest. KeywordsCOS Keywords:Immunology, Ion Channels, Signal Transduction.Additional Terms:Immunology, Ion Channels, Signal Transduction.Honors and Awards2002-2002,
Young Investigator Award,
American Pediatric Society/Society for Pediatric Research,
Basic Research
1985-1985,
B.S. summa cum laude,
Indiana University Bloomington,
Biochemistry
M.D. with Distinction,
University of North Carolina at Chapel Hill,
Medicine
Previous Positions1998-2000, Assistant Professor,
Harvard University,
Medical School,
Pathology
Publications- Nadler MJ, Hermosura MC, Inabe K, Perraud AL, Zhu Q, Stokes AJ, Kurosaki T, Kinet JP, Penner R, Scharenberg AM, Fleig A, LTRPC7 is a Mg.ATP-regulated divalent cation channel required for cell viability, Nature, 411(6837), 590-5, 2001
 - Perraud AL, Fleig A, Dunn CA, Bagley LA, Launay P, Schmitz C, Stokes AJ, Zhu Q, Bessman MJ, Penner R, Kinet JP, Scharenberg AM, ADP-ribose gating of the calcium-permeable LTRPC2 channel revealed by Nudix motif homology, Nature, 411(6837), 595-9, 2001
 - Saito K, Scharenberg AM, Kinet JP, Interaction between the Btk PH domain and phosphatidylinositol-3,4,5-trisphosphate directly regulates Btk, Journal of Biological Chemistry, 276(19), 16201-6, 2001
 - Scharenberg AM, The inhibitory receptor superfamily: potential relevance to atopy, Current Opinion in Immunology, 11(6), 621-5, December 1999
 - Beitz LO, Fruman DA, Kurosaki T, Cantley LC, Scharenberg AM, SYK is upstream of phosphoinositide 3-kinase in B cell receptor signaling, Journal of Biological Chemistry, 274(46), 32662-6, 1999
 - Maeda A, Scharenberg AM, Tsukada S, Bolen JB, Kinet JP, Kurosaki T, Paired immunoglobulin-like receptor B (PIR-B) inhibits BCR-induced activation of Syk and Btk by SHP-1, Oncogene, 18(14), 2291-7, 1999
 - Gupta N, Scharenberg AM, Fruman DA, Cantley LC, Kinet JP, Long EO, The SH2 domain-containing inositol 5'-phosphatase (SHIP) recruits the p85 subunit of phosphoinositide 3-kinase during FcgammaRIIb1-mediated inhibition of B cell receptor signaling, Journal of Biological Chemistry, 274(11), 7489-94, 1999
 - Scharenberg AM, Kinet JP, PtdIns-3,4,5-P3: a regulatory nexus between tyrosine kinases and sustained calcium signals, Cell, 94(1), 5-8, 1998
 - Fluckiger AC, Li Z, Kato RM, Wahl MI, Ochs HD, Longnecker R, Kinet JP, Witte ON, Scharenberg AM, Rawlings DJ, Btk/Tec kinases regulate sustained increases in intracellular Ca2+ following B-cell receptor activation, Embo Journal, 17(7), 1973-85, 1998
 - Scharenberg AM, El-Hillal O, Fruman DA, Beitz LO, Li Z, Lin S, Gout I, Cantley LC, Rawlings DJ, Kinet JP, Phosphatidylinositol-3,4,5-trisphosphate (PtdIns-3,4,5-P3)/Tec kinase-dependent calcium signaling pathway: a target for SHIP-mediated inhibitory signals, Embo Journal, 17(7), 1961-72, 1998
 - Gupta N, Scharenberg AM, Burshtyn DN, Wagtmann N, Lioubin MN, Rohrschneider LR, Kinet JP, Long EO, Negative signaling pathways of the killer cell inhibitory receptor and Fc gamma RIIb1 require distinct phosphatases, Journal of Experimental Medicine, 186(3), 473-8, 1997
 - El-Hillal O, Kurosaki T, Yamamura H, Kinet JP, Scharenberg AM, syk kinase activation by a src kinase-initiated activation loop phosphorylation chain reaction, Proceedings of the National Academy of Sciences (USA), 94(5), 1919-24, 1997
 - Scharenberg AM, Kinet JP, The emerging field of receptor-mediated inhibitory signaling: SHP or SHIP?, Cell, 87(6), 961-4, 1996
 - Binstadt BA, Brumbaugh KM, Dick CJ, Scharenberg AM, Williams BL, Colonna M, Lanier LL, Kinet JP, Abraham RT, Leibson PJ, Sequential involvement of Lck and SHP-1 with MHC-recognizing receptors on NK cells inhibits FcR-initiated tyrosine kinase activation, Immunity, 5(6), 629-38, December 1996
 - Ota Y, Beitz LO, Scharenberg AM, Donovan JA, Kinet JP, Samelson LE, Characterization of Cbl tyrosine phosphorylation and a Cbl-Syk complex in RBL-2H3 cells, Journal of Experimental Medicine, 184(5), 1713-23, 1996
 - Jabril-Cuenod B, Zhang C, Scharenberg AM, Paolini R, Numerof R, Beaven MA, Kinet JP, Syk-dependent phosphorylation of Shc. A potential link between FcepsilonRI and the Ras/mitogen-activated protein kinase signaling pathway through SOS and Grb2, Journal of Biological Chemistry, 271(27), 16268-72, 1996
 - Lin S, Cicala C, Scharenberg AM, Kinet JP, The Fc(epsilon)RIbeta subunit functions as an amplifier of Fc(epsilon)RIgamma-mediated cell activation signals, Cell, 85(7), 985-95, 1996
 - Park H, Wahl MI, Afar DE, Turck CW, Rawlings DJ, Tam C, Scharenberg AM, Kinet JP, Witte ON, Regulation of Btk function by a major autophosphorylation site within the SH3 domain, Immunity, 4(5), 515-25, May 1996
 - Rawlings DJ, Scharenberg AM, Park H, Wahl MI, Lin S, Kato RM, Fluckiger AC, Witte ON, Kinet JP, Activation of BTK by a phosphorylation mechanism initiated by SRC family kinases, Science, 271(5250), 822-5, 1996
 - Burshtyn DN, Scharenberg AM, Wagtmann N, Rajagopalan S, Berrada K, Yi T, Kinet JP, Long EO, Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor, Immunity, 4(1), 77-85, January 1996
 - Scharenberg AM, Lin S, Cuenod B, Yamamura H, Kinet JP, Reconstitution of interactions between tyrosine kinases and the high affinity IgE receptor which are controlled by receptor clustering, Embo Journal, 14(14), 3385-94, 1995
 - Hirasawa N, Scharenberg A, Yamamura H, Beaven MA, Kinet JP, A requirement for Syk in the activation of the microtubule-associated protein kinase/phospholipase A2 pathway by Fc epsilon R1 is not shared by a G protein-coupled receptor, Journal of Biological Chemistry, 270(18), 10960-7, 1995

Profile DetailsCOS Expertise ID #1001909 Individual Expertise profile of Andrew Scharenberg, Copyright Andrew Scharenberg. © COS Expertise TM, 2009, ProQuest LLC All rights reserved. |